NO304833B1 - Nye pyrrolokarbazoler - Google Patents

Nye pyrrolokarbazoler

Info

Publication number
NO304833B1
NO304833B1 NO953052A NO953052A NO304833B1 NO 304833 B1 NO304833 B1 NO 304833B1 NO 953052 A NO953052 A NO 953052A NO 953052 A NO953052 A NO 953052A NO 304833 B1 NO304833 B1 NO 304833B1
Authority
NO
Norway
Prior art keywords
pyrrolocarbazoles
new
lower alkyl
hydrogen
heteroaryl
Prior art date
Application number
NO953052A
Other languages
English (en)
Norwegian (no)
Other versions
NO953052D0 (no
NO953052L (no
Inventor
Chris Allen Broka
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO953052D0 publication Critical patent/NO953052D0/no
Publication of NO953052L publication Critical patent/NO953052L/no
Publication of NO304833B1 publication Critical patent/NO304833B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
NO953052A 1994-08-04 1995-08-03 Nye pyrrolokarbazoler NO304833B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28604394A 1994-08-04 1994-08-04

Publications (3)

Publication Number Publication Date
NO953052D0 NO953052D0 (no) 1995-08-03
NO953052L NO953052L (no) 1996-02-05
NO304833B1 true NO304833B1 (no) 1999-02-22

Family

ID=23096813

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953052A NO304833B1 (no) 1994-08-04 1995-08-03 Nye pyrrolokarbazoler

Country Status (29)

Country Link
US (1) US5721267A (cs)
EP (1) EP0695755B1 (cs)
JP (1) JP2672290B2 (cs)
KR (1) KR100326790B1 (cs)
CN (1) CN1051551C (cs)
AT (1) ATE172463T1 (cs)
AU (1) AU692563B2 (cs)
BR (1) BR9503536A (cs)
CA (1) CA2155148A1 (cs)
CO (1) CO4410329A1 (cs)
CZ (1) CZ288583B6 (cs)
DE (1) DE69505470T2 (cs)
DK (1) DK0695755T3 (cs)
ES (1) ES2123873T3 (cs)
FI (1) FI111258B (cs)
HU (1) HU225567B1 (cs)
IL (1) IL114785A (cs)
MA (1) MA23639A1 (cs)
MY (1) MY117092A (cs)
NO (1) NO304833B1 (cs)
NZ (1) NZ272687A (cs)
PE (1) PE34996A1 (cs)
PL (1) PL180801B1 (cs)
RU (1) RU2162089C2 (cs)
SA (1) SA95160203B1 (cs)
TR (1) TR199500954A1 (cs)
TW (1) TW403652B (cs)
UY (1) UY24010A1 (cs)
ZA (1) ZA956327B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283203B1 (it) * 1996-03-07 1998-04-16 Ausimont Spa Composizioni estinguenti la fiamma
US6020298A (en) * 1997-03-05 2000-02-01 Ausimont S.P.A. Solvent cleaning agents including additives of the formula Rf -CFX-L containing perfluoroalkylenic units
DE19744257B4 (de) * 1997-10-07 2004-04-15 Zentaris Gmbh Beta-Carboline und deren Verwendung zur Behandlung von malignen und anderen, auf pathologischen Zellproliferationen beruhenden Erkrankungen
US7122679B2 (en) 2000-05-09 2006-10-17 Cephalon, Inc. Multicyclic compounds and the use thereof
JPWO2003051883A1 (ja) * 2001-12-18 2005-04-28 協和醗酵工業株式会社 インドール誘導体
EP1501831A1 (en) * 2002-04-26 2005-02-02 Warner-Lambert Company Llc Inhibitors of checkpoint kinases (wee1 and chk1)
US7094798B1 (en) 2002-04-26 2006-08-22 Pfizer Inc Inhibitors of checkpoint kinases (Wee1 and Chk1)
JP2012051804A (ja) * 2008-12-26 2012-03-15 Kyoto Univ Eg5阻害剤
RU2404983C1 (ru) * 2009-06-08 2010-11-27 Федеральное Государственное Образовательное Учреждение Высшего Профессионального Образования "Южный Федеральный Университет" СПОСОБ ПОЛУЧЕНИЯ 2-R1-6-R2-5-АРИЛ-ПИРРОЛО[3,4-с]КАРБАЗОЛ-1,3(2Н,6Н)-ДИОНОВ
MA33418B1 (fr) * 2009-06-10 2012-07-03 Chugai Pharmaceutical Co Ltd Composé tétracyclique
SG187614A1 (en) 2010-08-20 2013-03-28 Chugai Pharmaceutical Co Ltd Composition containing tetracyclic compound
CA2885722C (en) 2012-09-25 2020-06-02 Chugai Seiyaku Kabushiki Kaisha Ret inhibitor
KR101577098B1 (ko) 2012-11-20 2015-12-14 주식회사 두산 유기 화합물 및 이를 포함하는 유기 전계 발광 소자
PL3135287T3 (pl) 2014-04-25 2025-03-31 Chugai Seiyaku Kabushiki Kaisha Preparat zawierający związek tetracykliczny w dużej dawce
KR20160142383A (ko) 2014-04-25 2016-12-12 추가이 세이야쿠 가부시키가이샤 4환성 화합물의 신규 결정
TWI803187B (zh) 2014-08-08 2023-05-21 日商中外製藥股份有限公司 包含4環性化合物的非晶質體之固體分散體及製劑
WO2016114375A1 (ja) 2015-01-16 2016-07-21 中外製薬株式会社 併用医薬
WO2020050241A1 (ja) 2018-09-04 2020-03-12 中外製薬株式会社 4環性化合物の製造方法
KR102509614B1 (ko) * 2022-08-09 2023-03-13 김학수 부직포 패널 제조방법 및 제조장치

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8611762D0 (en) * 1986-05-14 1986-06-25 Wellcome Found Polycyclic biocidal compounds
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
DE3833008A1 (de) * 1988-09-29 1990-04-05 Goedecke Ag Pyrrolocarbozol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
MC2096A1 (fr) * 1989-02-23 1991-02-15 Hoffmann La Roche Pyrroles substitues
GB2239013B (en) * 1989-11-01 1993-06-02 Toyama Chemical Co Ltd Novel isoindole derivatives and salts thereof,processes for producing the same and antitumor agent comprising the same
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung
AU678435B2 (en) * 1993-05-10 1997-05-29 F. Hoffmann-La Roche Ag Substituted pyrroles
AU679752B2 (en) * 1993-05-28 1997-07-10 Cephalon, Inc. Use of indolocarbazole derivatives to treat a pathological condition of the prostate

Also Published As

Publication number Publication date
HK1012341A1 (en) 1999-07-30
HU9502270D0 (en) 1995-09-28
DE69505470T2 (de) 1999-05-12
NO953052D0 (no) 1995-08-03
PE34996A1 (es) 1996-10-01
JP2672290B2 (ja) 1997-11-05
NZ272687A (en) 1997-04-24
IL114785A0 (en) 1995-11-27
CZ288583B6 (cs) 2001-07-11
SA95160203B1 (ar) 2005-07-31
FI111258B (fi) 2003-06-30
IL114785A (en) 1998-06-15
DE69505470D1 (de) 1998-11-26
KR960007592A (ko) 1996-03-22
US5721267A (en) 1998-02-24
PL180801B1 (pl) 2001-04-30
TR199500954A1 (tr) 1996-10-21
CZ199795A3 (en) 1996-02-14
HU225567B1 (en) 2007-03-28
DK0695755T3 (da) 1999-06-28
TW403652B (en) 2000-09-01
NO953052L (no) 1996-02-05
EP0695755B1 (en) 1998-10-21
KR100326790B1 (ko) 2002-07-27
CO4410329A1 (es) 1997-01-09
MY117092A (en) 2004-05-31
BR9503536A (pt) 1996-06-04
CN1051551C (zh) 2000-04-19
CA2155148A1 (en) 1996-02-05
PL309874A1 (en) 1996-02-05
FI953710A0 (fi) 1995-08-03
MA23639A1 (fr) 1996-04-01
RU2162089C2 (ru) 2001-01-20
EP0695755A1 (en) 1996-02-07
AU692563B2 (en) 1998-06-11
ATE172463T1 (de) 1998-11-15
ZA956327B (en) 1996-02-04
ES2123873T3 (es) 1999-01-16
FI953710L (fi) 1996-02-05
JPH0859666A (ja) 1996-03-05
AU2722095A (en) 1996-02-15
HUT73437A (en) 1996-07-29
UY24010A1 (es) 2000-12-29
CN1123280A (zh) 1996-05-29

Similar Documents

Publication Publication Date Title
NO304833B1 (no) Nye pyrrolokarbazoler
DK0698606T3 (da) Azolylaminderivat
AU667920B2 (en) New piperidine derivatives of benzimidazole
AU9281198A (en) Benzofuran derivatives
DK240084D0 (da) New beta-carboline-3-oxadiazolyl derivatives
ATE45354T1 (de) Chinoloncarbonsaeurederivate.
NO944371L (no) Kjemisk forbindelse med blodplateaggregeringsinhibiotoraktivitet
DK1031556T3 (da) 2-phenoxyanilinderivater
ITMI931012A1 (it) Composti spiro-piranici dotati di caratteristiche fotocromatiche
ATE156486T1 (de) Fungizide 3,4-diaryl-(5h)-furan-2-onederivate
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
ATE105565T1 (de) Pradimicinderivate.
FI903967A0 (fi) Nya imidazolderivat.
EP0421668A3 (en) 1,4-dihydro-4-oxo-3-quinolone derivatives as selectively toxic mammalian antibacterial agents